Procurement Must Look Beyond Price To Ensure Supply Chain Security

Criteria Must Reward Non-Price Aspects In Wake Of COVID-19

A globally co-ordinated approach to sourcing that rewards non-pricing criteria is imperative to bolster the security of the off-patent industry’s supply chain in the wake of the coronavirus pandemic, James Burt tells Generics Bulletin in the second part of our exclusive interview.

Drugs
Medicines procurement criteria must go beyond price • Source: Shutterstock

In the first part of our interview with James Burt – Accord’s executive vice-president for Europe, the Middle East and North Africa – he laid out the key actions taken by the European generics industry to mitigate the coronavirus pandemic over the past weeks and months. (Also see "European Industry Played Key Role In Mitigating COVID-19" - Generics Bulletin, 30 July, 2020.)

Now, in the second part of our exclusive interview, Burt tells Generics Bulletin what the off-patent industry can expect in...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Drug Pricing

More from Policy & Regulation

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Policy&Regulation-Free: Article with different widgets

    Emerging CRISPR innovations, shifting regulatory landscapes, and rising partnerships are accelerating a paradigm shift in biotech pipelines

  • Overseas API Manufacturing Identified As Key Vulnerability In US Supply Chain

    After US President Joe Biden launched a review of the country’s API supply chain, the task force has reported back with key vulnerabilities that contribute to drug shortages and supply risks during a global public health emergency. According to the report, the lack of geographic diversity and dependence on foreign nations and anti-competitive actions by foreign nations are key areas of concern.